Applied Genetic Technologies Corp (NASDAQ:AGTC) shares lost 32% of their value today, after the gene therapy company provided a quarterly corporate update, showing that progress …
Applied Genetic Technologies Corp (NASDAQ:AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, …
On July 2 before market open, Biogen Inc (NASDAQ:BIIB) and Applied Genetic Technologies Corp (NASDAQ:AGTC) announced a broad collaboration and license agreement to …